Lista de obras - Michael J Kozal - Dominio Público Uruguay

A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients ⬇️

artículo científico publicado el 1 de marzo de 1993

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP

artículo científico publicado en 2006

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results

artículo científico publicado en 2012

A study of financial incentives to reduce plasma HIV RNA among patients in care.

artículo científico publicado en 2013

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

artículo científico publicado en 2007

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care.

artículo científico publicado en 2004

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

artículo científico publicado en 2013

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

artículo científico publicado en 2016

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

artículo científico publicado en 1994

Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection

artículo científico publicado en 2015

Deep sequencing of HIV: clinical and research applications

artículo científico

Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management

artículo científico publicado en 2009

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

artículo científico publicado en 2012

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.

artículo científico publicado en 1994

Does the duration of untreated psychosis affect prognosis in schizophrenia?

artículo científico

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.

artículo científico publicado en 2004

Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.

artículo científico publicado en 2011

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

artículo científico publicado en 1996

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

artículo científico publicado en 2016

HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection Drug Users

article

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

artículo científico publicado en 2012

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

artículo científico publicado en 2009

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

artículo científico publicado en 2011

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

artículo científico publicado en 2014

Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.

artículo científico publicado en 1993

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance

scientific article published on 01 January 2007

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

artículo científico publicado en 2010

Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients

artículo científico publicado en 2006

Prevalence of HIV-1 syncytium-inducing phenotype

artículo científico publicado en 1994

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

artículo científico publicado en 2014

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

artículo científico publicado en 2005

Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.

artículo científico publicado en 2011

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

artículo científico publicado en 2012

The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies

artículo científico publicado en 2007

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

artículo científico publicado en 1996

Transmission of HIV drug resistance: lessons from sensitive screening assays.

artículo científico publicado en 2015

Use of new technologies to detect and understand HIV drug resistance.

artículo científico publicado en 2010

Using oligonucleotide probe arrays to access genetic diversity.

artículo científico publicado en 1995

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

artículo científico publicado en 2012

Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.

artículo científico publicado en 2008

Lista de obras de Michael J Kozal

A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients ⬇️

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results

A study of financial incentives to reduce plasma HIV RNA among patients in care.

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection

Deep sequencing of HIV: clinical and research applications

Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.

Does the duration of untreated psychosis affect prognosis in schizophrenia?

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.

Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection Drug Users

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients

Prevalence of HIV-1 syncytium-inducing phenotype

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

Transmission of HIV drug resistance: lessons from sensitive screening assays.

Use of new technologies to detect and understand HIV drug resistance.

Using oligonucleotide probe arrays to access genetic diversity.

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.